Drug Trial Radar · NCT02680756
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Last checked: Nov 20, 2026Latest source record: Nov 2, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
250
Actual
Start
Jan 2016
Primary completion
Oct 2018
Study completion Jan 2019
Sponsor
- Lead sponsor
- Shield TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Feb 11, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the efficacy of ferric maltol and intravenous iron (IVI) Ferric Carboxy Maltose in the treatment of iron deficiency anaemia (IDA) and subsequent maintenance of haemoglobin in subjects with Inflammatory Bowel Disease (IBD).
Conditions
- Anemia, Iron-Deficiency
- Inflammatory Bowel Disease
- Crohn's Disease
Interventions
Ferric MaltolDrug
Ferric Carboxy MaltoseDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Subjects Achieving Either a 2g/dL Increase in Hb OR Normalization of Hb at Week 12Time frame: Baseline to Week 12
- Number of Subjects Achieving Either a 2g/dL Increase in Hb OR Normalization of Hb at Week 12Time frame: Baseline to Week 12
Locations
44 sites in 6 countries. Site status is shown where the registry gives one.
Site not named
Dothan, Alabama
Site not named
Tucson, Arizona
Site not named
Gainesville, Florida
Site not named
Hollywood, Florida
Site not named
Chevy Chase, Maryland
Site not named
Saint Paul, Minnesota
Site not named
St Louis, Missouri
Site not named
Great Neck, New York
Site not named
Lima, Ohio
Site not named
Germantown, Tennessee
Site not named
Nashville, Tennessee
Site not named
Beaumont, Texas
Site not named
Houston, Texas
Site not named
San Antonio, Texas
Site not named
Bountiful, Utah
Site not named
Bellevue, Washington
Site not named
Seattle, Washington
Site not named
Ghent, Belgium
Site not named
Clichy, France
Site not named
Lille, France
Site not named
Lyon, France
Site not named
Saint-Etienne, France
Site not named
Salouël, France
Site not named
Vandœuvre-lès-Nancy, France
Site not named
Berlin, Germany
Site not named
Dresden, Germany
Site not named
Hamburg, Germany
Site not named
Herne, Germany
Site not named
Jena, Germany
Site not named
Leipzig, Germany
Site not named
Lübeck, Germany
Site not named
Lüneburg, Germany
Site not named
Minden, Germany
Site not named
Oldenburg, Germany
Site not named
Schweinfurt, Germany
Site not named
Budapest, Hungary
Site not named
Miskolc, Hungary
Site not named
Szeged, Hungary
Site not named
Barcelona, Spain
Site not named
Córdoba, Spain
Showing 40 of 44 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.